Affiliation:
1. Department of Pharmaceutics, Dubai Pharmacy College for Girls, Dubai, UAE
2. Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Kuala Lumpur 57000, Malaysia
Abstract
Background:
This study aims to assess the suitability of in vitro drug release methods, dialysis and paddle methods for predicting in vivo behaviour of Aceclofenac (ACE) proniosomes.
Methods:
ACE proniosomes are prepared using different carriers: glucose, maltodextrin and manni-tol by the slurry method. The release studies of ACE proniosomes formulations were performed us-ing the paddle, and dialysis methods while in vivo studies were performed in albino rats. Graphical presentation, model-dependent and model-independent approaches were applied to compare two dissolution methods.
Results:
More than 70% of the drug was released from ACE proniosomes over 60 min by paddle method while not more than 5% was released in the same period by dialysis method. The paddle method provides a reproducible and faster release, whereas poor drug release occurred with the di-alysis method. For the paddle method, lower values of similarity factor (f2) and greater differences in the dissolution efficiency (DE) amongst different formulations and in comparison, to that of the pure drug indicates that it is a more discriminative method compared to dialysis. The paddle method also illustrated high regression coefficients (r2) of 0.81, 0.998 and 0.975 for FN1, FN2, and FN3, respectively for level A IVIVC, while poor or no relation (r2 < 0.1) was detected in the case of dialy-sis method.
Conclusion:
Based on the results, the paddle method is concluded to be the more suitable method compared to the dialysis method for in vitro drug release studies of a novel dosage form such as proniosomes.
Publisher
Bentham Science Publishers Ltd.
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference46 articles.
1. Sakore S.; Chakraborty B.; In vitro-in vivo correlation (IVIVC): a strategic tool in drug development. J Bioequivalence Bioavailab 2011,3,1-12
2. Uppoor V.R.S.; Regulatory perspectives on in vitro (dissolution)/in vivo (bioavailability) correlations. J Control Release 2001,72(1-3),127-132
3. Emami J.; In vitro - in vivo correlation: from theory to applications. J Pharm Pharm Sci 2006,9(2),169-189
4. D’Souza S.S.; DeLuca P.P.; Methods to assess in vitro drug release from injectable polymeric particulate systems. Pharm Res 2006,23(3),460-474
5. Ranjan A.; Jha P.K.; Experiments and modeling of controlled release behavior of commercial and model polymer-drug formulations using dialysis membrane method. Drug Deliv Transl Res 2020,10(2),515-528